These include reductions in EAT, improvements in renal function and diuretic resistance, enhancement of microvascular dysfunction and myocardial energetics, modulation of the renin–angiotensin system, and better management of the AF-HFpEF vicious cycle. The gene discussed is REN; the disease is atrial fibrillation.